blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0930076

EP0930076 - Pharmaceutical compositions comprising CS-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma [Right-click to bookmark this link]
Former [1999/29]MEDICINAL COMPOSITIONS
[2004/24]
StatusNo opposition filed within time limit
Status updated on  07.10.2005
Database last updated on 24.04.2024
Most recent event   Tooltip07.10.2005No opposition filed within time limitpublished on 23.11.2005  [2005/47]
Applicant(s)For all designated states
Sankyo Company Limited
5-1 Nihonbashi Honcho 3-chome Chuo-ku
Tokyo 103-0023 / JP
[N/P]
Former [1999/29]For all designated states
SANKYO COMPANY LIMITED
5-1 Nihonbashi Honcho 3-chome
Chuo-ku, Tokyo 103-0023 / JP
Inventor(s)01 / TSUJITA, Yoshio, Sankyo Company, Limited
2-58, Hiromachi 1-chome, Shinagawa-ku
Toyko 140 / JP
02 / FUJIWARA, Toshihiko, Sankyo Company, Limited
2-58, Hiromachi 1-chome, Shinagawa-ku
Toyko 140 / JP
03 / SADA, Toshio, Sankyo Company, Limited
2-58, Hiromachi 1-chome, Shinagawa-ku
Toyko 140 / JP
04 / MAEDA, Naoyuki, Sankyo Company, Limited
2-58, Hiromachi 1-chome, Shinagawa-ku
Toyko 140 / JP
[1999/29]
Representative(s)Gibson, Christian John Robert
Marks & Clerk LLP 90 Long Acre London
WC2E 9RA / GB
[N/P]
Former [1999/29]Gibson, Christian John Robert
MARKS & CLERK, 57/60 Lincoln's Inn Fields
London WC2A 3LS / GB
Application number, filing date97930762.611.07.1997
[1999/29]
WO1997JP02407
Priority number, dateJP1996018436815.07.1996         Original published format: JP 18436896
[1999/29]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9802183
Date:22.01.1998
Language:EN
[1998/03]
Type: A1 Application with search report 
No.:EP0930076
Date:21.07.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 22.01.1998 takes the place of the publication of the European patent application.
[1999/29]
Type: B1 Patent specification 
No.:EP0930076
Date:01.12.2004
Language:EN
[2004/49]
Search report(s)International search report - published on:JP22.01.1998
(Supplementary) European search report - dispatched on:EP20.08.2001
ClassificationIPC:A61K45/06, A61K31/33, A61P9/10, A61P43/00
[2004/24]
CPC data not yet available
Former IPC [1999/29]A61K45/06, A61K31/33
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/29]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN enthaltend CS-866 und INSULINRESISTENZ VERBESSERNDEM MITTELN und deren Verwendung zur Behandlung von Arteriosklerose und XANTHOM[2004/24]
English:Pharmaceutical compositions comprising CS-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma[2004/24]
French:Compositions pharmaceutiques comprenant CS-866 et des agents reforçants de la resistance a l'insuline et leur utilisation pour le traitement de la sclerose en plaques et du xanthome[2004/24]
Former [1999/29]PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
Former [1999/29]MEDICINAL COMPOSITIONS
Former [1999/29]COMPOSITIONS MEDICINALES
Entry into regional phase18.01.1999Translation filed 
28.01.1999National basic fee paid 
28.01.1999Search fee paid 
28.01.1999Designation fee(s) paid 
28.01.1999Examination fee paid 
Examination procedure11.07.1997Request for preliminary examination filed
International Preliminary Examining Authority: JP
28.01.1999Examination requested  [1999/29]
11.01.2002Request for decision received: (all rights)
18.02.2002Result of request for decision ((all rights)): Request accepted
24.06.2002Despatch of a communication from the examining division (Time limit: M04)
24.10.2002Reply to a communication from the examining division
20.06.2003Despatch of a communication from the examining division (Time limit: M02)
20.08.2003Reply to a communication from the examining division
24.05.2004Communication of intention to grant the patent
22.09.2004Fee for grant paid
22.09.2004Fee for publishing/printing paid
Divisional application(s)EP01124669.1  / EP1175902
Opposition(s)02.09.2005No opposition filed within time limit [2005/47]
Fees paidRenewal fee
13.07.1999Renewal fee patent year 03
12.07.2000Renewal fee patent year 04
12.07.2001Renewal fee patent year 05
12.07.2002Renewal fee patent year 06
14.07.2003Renewal fee patent year 07
14.07.2004Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0219782  (HOECHST AG [DE]) [Y] 1-46 * claim - *;
 [DY]EP0332332  (PFIZER [US]) [DY] 1-46 * page 3, line 18 - line 32; claim - *;
 [Y]EP0411395  (THERA PATENT VERWALTUNGS GMBH [DE]) [Y] 1-46 * claim - *;
 [Y]EP0425956  (SQUIBB & SONS INC [US]) [Y] 1-46 * claim - *;
 [DY]US5223522  (CLARK DAVID A [US], et al) [DY] 1-46 * column 1, line 45 - column 2, line 4; claim - *;
 [Y]EP0603419  (JAPAN TOBACCO INC [JP]) [Y] 1-46 * page 70, paragraph L; claim - *;
 [Y]WO9419347  (SANKYO CO [JP], et al) [Y] 1-46* abstract *;
 [YD]WO9526188  (MERCK & CO INC [US], et al) [YD] 1-46 * claim - *
International search[A]  - TORU MURAKAMI, NOBUHIRO YAMADA, "STRIDES OF MEDICINE, (1995), Vol. 174, No. 10, TORU MURAKAMI, NOBUHIRO YAMADA, Can ACE Inhibitors Prevent Arteriosclerosis? (in Japanese)", STRIDES OF MEDICINE, XX, JP, JP, (19950902), vol. 174, no. 10, pages 810 - 813, XP002965198
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.